MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting data on Vanoglipel (DA-1241), a ...

Hoth Therapeutics, Inc. , a biopharmaceutical company focused on developing breakthrough therapies for metabolic, dermatologic, and inflammatory diseases, today announced the initiation of a U.S.

As National Liver Awareness Month unfolds, specialists are sounding the alarm on the rising rates of liver disease.

Exposure to tetrachloroethylene might triple the risk of significant liver fibrosis -- an excessive amount of liver scarring ...

Higher visceral adipose tissue volume was linked to higher carotid wall volume in Canadian cohort and higher carotid-intima media thickness.